Investing Profile

Naveen Krishnan

InvestorVC
Senior Director at Leaps by Bayer
leaps.bayer.com/teamBerlin, Germany
Photo of Naveen Krishnan, Investor at Leaps by Bayer

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Accent Therapeutics
Series CJan 2024$75M
$180M
Co-investors: Larry Lasky (The Column Group), Jason Rhodes (Atlas Venture)
Edifice Health
Series AApr 2021$12M
$12M